| Product NDC: | 0615-6547 |
| Proprietary Name: | Metoprolol Tartrate |
| Non Proprietary Name: | metoprolol tartrate |
| Active Ingredient(s): | 25 mg/1 & nbsp; metoprolol tartrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0615-6547 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076704 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110505 |
| Package NDC: | 0615-6547-31 |
| Package Description: | 31 TABLET, FILM COATED in 1 BLISTER PACK (0615-6547-31) |
| NDC Code | 0615-6547-31 |
| Proprietary Name | Metoprolol Tartrate |
| Package Description | 31 TABLET, FILM COATED in 1 BLISTER PACK (0615-6547-31) |
| Product NDC | 0615-6547 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | metoprolol tartrate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20110505 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | METOPROLOL TARTRATE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |